OpenEvidence Acquires AI Advertising Startup Amaro

September 12, 2025
OpenEvidence has acquired Amaro, an AI-native advertising company backed by Google Ventures, to enhance its healthcare platform capabilities.

OpenEvidence has acquired Amaro, an AI-native advertising company, announced in a press release. Amaro, backed by Google Ventures and Greycroft, specializes in optimizing advertising deployment through intelligent automation.

The acquisition aims to expand OpenEvidence's platform capabilities, particularly in building a modern advertising infrastructure for healthcare professionals. OpenEvidence, which powers over half a million clinical conversations daily, sees this acquisition as a strategic fit to accelerate its growth and enhance its ad-supported model.

Amaro's team and technology will integrate into OpenEvidence's operations, supporting its mission to provide high-quality information to clinicians. This move follows OpenEvidence's recent $210 million Series B financing, valuing the company at $3.5 billion.

We hope you enjoyed this article.

Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.

Also, consider following us on social media:

Healthcare & Life Sciences AI AI Brief AI Brief (X)

More from: Life Sciences

09/04
ODYSS Unveils N1 AI Necklace for Food Logging
09/04
Withings Adds AI Heart and Lung Sound Analysis to BeamO
09/03
CluePoints Releases Three AI Tools for Clinical Data Review
09/03
Authenticx Adds Form Automation and Routing to Safety AI
09/03
Superluminal Medicines Raises $60 Million for Obesity Drug Trial

Subscribe to Life AI Weekly

Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.

AI Token Webinar

Market report

2025 Generative AI in Professional Services Report

Thomson Reuters

This report by Thomson Reuters explores the integration and impact of generative AI technologies, such as ChatGPT and Microsoft Copilot, within the professional services sector. It highlights the growing adoption of GenAI tools across industries like legal, tax, accounting, and government, and discusses the challenges and opportunities these technologies present. The report also examines professionals' perceptions of GenAI and the need for strategic integration to maximize its value.

Read more

You May Also Like